Further study confirmed that SOD2 overexpression is a biomarker in predicting poorer prognosis with endometrioid ovarian carcinoma and shows extreme resistance to chemotherapeutics-mediated oxidative stress [85]. Here, SOD2 is linked to ovarian endometrioid carcinoma.